<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Original Research ArticleInternational Journal of Reproduction, Contraception, Obstetrics and Gynecology

Publication:
Serum lactate dehydrogenase: a prognostic factor in pre-eclampsia

Int J Reprod Contracept Obstet Gynecol. 2019;8(7):2792-2798.DOI10.18203/2320-1770.ijrcog20193044

Thumbnail Image
View on the journal's website(opens in a new tab)

Abstract

Background Pre eclampsia is responsible for significant maternal and perinatal morbidity and mortality worldwide .Serum LDH level is a useful biomarker for cellular injury which may reflect the severity of pre eclampsia and its level might be a guideline for management of patients. The aim of study was to find out the role of serum LDH in prediction of adverse outcome of pre eclampsia, severity of disease and occurrence of complications.

Methods This prospective observational study was conducted in the department of Obstetrics and Gynecolog, RIMS, Ranchi, Jharkhand, India. A total of 300 cases were studied.150 cases were non severe preeclamptic and 150 cases were severe pre eclamptic patients. Serum LDH was done in both non severe and severe eclamptic patients .Data entry was done in Microsoft excel 2007. Results were analysed by chi square test.

Results Higher LDH levels had significant correlation with high blood pressure as well as poor maternal and perinatal outcome.

Conclusions High serum LDH level correlate well with the severity of disease and poor outcome in patients of pre eclampsia. Detection of high risk patients with increased levels of LDH mandate close monitoring and management to prevent maternal and fetal morbidity and mortality.

Keywords

Affiliations

  1. Department of Obstetrics and Gynecology, RIMS, Ranchi, Jharkhand, India
  2. Department of Community Medicine, RIMS, Ranchi, Jharkhand, India

Full item record